JAK2 and myeloproliferative neoplasm: The ability to demonstrate the presence of this mutation has not only simplified the diagnosis of MPN but also ensured greater diagnostic accuracy.5 The identification of this mutation has also led to the development of therapies targeted at inhibition of the JAK2 kinase.7,8